| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $18,011,739 ) (Continued on the next page) |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148576 | Vaccine and Treatment Evaluation Units | 000 | 7 | NIH | 12/29/2025 | $560,000 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA276135 | Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML | 000 | 3 | NIH | 12/10/2025 | $482,689 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA275964 | Targeting leukemic stem cells in acute myeloid leukemia | 000 | 4 | NIH | 12/19/2025 | $379,944 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI189249 | Imaging protease activation and maturation of single HIV-1 particles | 000 | 2 | NIH | 11/24/2025 | $463,600 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI188896 | Coordination of innate and cellular mucosal immunity in SARS-CoV-2 clearance | 000 | 2 | NIH | 12/3/2025 | $721,118 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI167724 | Optimizing AAV delivery of bNAbs for HIV prevention | 000 | 5 | NIH | 12/2/2025 | $908,180 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI072435 | Characterization of Lamprey B cells and Antibodies | 000 | 19 | NIH | 12/4/2025 | $536,005 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG094161 | Poly (ADP-ribose) polymerase ligand discovery for Alzheimer's disease | 000 | 2 | NIH | 12/26/2025 | $702,682 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI127799 | Host dependence of influenza A virus spatio-temporal dynamics | 000 | 7 | NIH | 12/4/2025 | $655,556 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI112787 | Targeting PD-1 Pathway for Functional Cure of AIDS | 000 | 13 | NIH | 12/30/2025 | $907,904 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K22AG088144 | Preparedness for Caregiving in Experienced Caregivers of Persons Living with Dementia | 000 | 2 | NIH | 12/10/2025 | $161,913 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23DK138267 | In-hospital use of Automated Insulin Delivery (AID): Current state and future potential | 000 | 3 | NIH | 12/24/2025 | $178,410 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K01NS124912 | Sympathetic Function in Neural Injuries | 000 | 5 | NIH | 12/17/2025 | $241,181 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F32HD112128 | Physiologically-inspired exoskeleton controller to enhance human balance | 000 | 2 | NIH | 12/18/2025 | $83,224 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F32AI189066 | Investigating the role of intrahepatic plasma cells in the clearance of HCV infection: implications for rational vaccine design | 000 | 2 | NIH | 11/26/2025 | $46,797 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31NS141610 | Novelty and valence encoding in the zona incerta in parkinsonian monkeys | 000 | 2 | NIH | 12/5/2025 | $49,538 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI189070 | Drivers of the beneficial effects of influenza A virus co-infection | 000 | 2 | NIH | 12/29/2025 | $49,538 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31AI174951 | Structural and Biochemical Effects of Capsid-targeting Molecules on HIV-1 Capsid Assembly | 000 | 4 | NIH | 12/4/2025 | $49,538 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31CA278008 | The role of DPF2 stability in SMARCB1-deficient cancers | 000 | 3 | NIH | 12/10/2025 | $49,538 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | F31DC022802 | The role of mouse auditory cortex and inferior colliculus in recovery from hearing loss | 000 | 2 | NIH | 11/26/2025 | $49,538 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | H7607848 | Ryan White Part C Outpatient EIS Program | 00 | 20 | HRSA | 12/29/2025 | $221,064 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM148217 | The Gut as a Target to Improve Outcomes in Sepsis | 000 | 4 | NIH | 12/15/2025 | $478,890 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R35GM156739 | Lipoprotein trafficking to the bacterial outer membrane | 000 | 2 | NIH | 12/12/2025 | $391,145 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS132884 | ATIC is a novel molecular target in diffuse intrinsic pontine glioma | 000 | 3 | NIH | 12/12/2025 | $373,226 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R21AI189247 | Novel HIV capsid-targeting antivirals maintain activity against lenacapavir-resistant viruses | 000 | 2 | NIH | 12/30/2025 | $234,175 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01NS125143 | Optimizing Patient-Specific Deep Brain Stimulation Models Using Electrophysiology | 000 | 5 | NIH | 12/18/2025 | $443,134 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH131910 | Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients with Schizophrenia Using an Anti-Inflammatory Challenge | 000 | 4 | NIH | 12/19/2025 | $585,197 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01MH133612 | Elucidating the Signaling Landscapes Underlying Cellular and Regional Specification During Human Brain Development | 000 | 3 | NIH | 11/26/2025 | $760,493 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01GM144563 | Actin regulation by cyclase-associated protein | 000 | 3 | NIH | 12/9/2025 | $281,700 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01GM144729 | Acylations: a novel pathway in the response to mitochondrial energy dysfunction | 000 | 5 | NIH | 12/22/2025 | $281,700 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01ES032440 | Interaction of Pyrethroid Exposure and the Microbiome on Parkinson's Disease related Pathologies | 000 | 5 | NIH | 12/22/2025 | $346,685 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DK131189 | Rapid quantitative renal fibrosis evaluation with dual-mode microscopy | 000 | 5 | NIH | 12/18/2025 | $504,172 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC020749 | Advancing primate models of human auditory cognitive control | 000 | 4 | NIH | 12/5/2025 | $405,157 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01DC021478 | Dissecting the first layer of central taste processing in Drosophila | 000 | 3 | NIH | 11/21/2025 | $340,158 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA281148 | Targeting PGC1β/PPARγ axis for overcoming acquired resistant to third generation EGFR-TKIs | 000 | 3 | NIH | 12/11/2025 | $436,031 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA277686 | Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma | 000 | 4 | NIH | 12/22/2025 | $320,831 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA295722 | Racial Disparities in the Mechanisms of Prostate Cancer Metastasis | 000 | 2 | NIH | 12/17/2025 | $573,468 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI069418 | Emory-CDC CTU | 000 | 20 | NIH | 12/18/2025 | $1,761,406 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA289761 | Functional consequences of SMARCB1 variants | 000 | 2 | NIH | 12/15/2025 | $470,970 |
| | 2026 | 2026 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | UM1AI148576 | Vaccine and Treatment Evaluation Units | 000 | 7 | NIH | 12/29/2025 | $645,005 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01CA259192 | Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia | 000 | 5 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AT011267 | Neural Mechanisms of Vibroacoustically Augmented Breath Focused Mindfulness for Dissociative Traumatized People | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AI162267 | HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles | 000 | 5 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG070937 | The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | 000 | 5 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG070060 | Ligand discovery for delineating cholesterol homeostasis in the brain | 000 | 6 | NIH | 10/28/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG079199 | Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease | 000 | 2 | NIH | 11/22/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | R01AG067736 | High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease | 000 | 5 | NIH | 12/12/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | P30AI168386 | Emory/Georgia TB Research Advancement Center (TRAC) | 000 | 4 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | EMORY UNIVERSITY | 201 DOWMAN DR NE | ATLANTA | GA | 30322-1061 | DEKALB | USA | K23AG066931 | Association of Perceived Stress and Cognition | 000 | 5 | NIH | 10/10/2025 | $0 |
|
